Skip To Main Content
Sergio Sanchez Luquin on Muck Rack

Sergio Sanchez Luquin

As seen in: Science Magazine
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Sergio Sanchez

Contact Sergio Sanchez, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Dasatinib reversibly disrupts T cell motility and activation in lymph nodes

|
By Irene Varela-Martínez, Zhenlan Yao, Da-Hyun Kim, Daniela Claudino Carvoeiro, Ana Marcos-Jiménez, Ilya Tsukalov, Sergio Sanchez Luquin, Ihssane Eladnani, Raquel Hernanz, Ana Briones, Enrique Martin-Gayo, Cecilia Muñoz-Calleja, Jens V. Stein
| Science Magazine Verified
Abstract INTRODUCTION RESULTS DISCUSSION MATERIALS AND METHODS Acknowledgments Supplementary Materials REFERENCES Information & Authors Metrics & Citations View Options References Figures Tables Media Share Abstract The tyrosine kinase inhibitor dasatinib is prescribed as a first-line treatment for Philadelphia chromosome–positive leukemias and is increasingly used in other clinical settings.
Open in Who Shared Issue with article?
See all 1 articles